Academy of General Dentistry Foundation Accepting Applications for Outreach Grants

The mission of theAcademy of General Dentistry Foundation, the philanthropic partner of theAcademy of General Dentistry, is to  support the efforts of the general dentist to improve  the oral health of the public.To that end, the foundation’s grant program supports efforts to provide access to quality healthcare for underserved populations. In 2014, the program will award one-year grants of up ... Read More »

NIH: Pharmacometric Modeling and Simulation for Generic Drugs Evaluation (U01): RFA-FD-04-001: Due: June 1, 2014

The purpose of this project is to develop quantitative pharmacometric models for generic drugs evaluation, in the following areas (1) narrow therapeutic index (NTI) drugs, (2) generic drug substitutability and post marketing risk assessment, and (3) partial AUCs (area under the concentration vs. time curve) as bioequivalence criteria. Each area is a subtopic of this grant and described in Section ... Read More »

FDA: Dissolution Methods for Microsphere and Implant Drug Products (U01): RFA-FD-14-007

There is a lack of compendial or biorelevant in vitro drug release assays for parenteral sustained release dosage forms.  These products include microspheres and biodegradable/non-biodegradable implants.  The purpose of this study is to investigate dissolution methods for a parenteral sustained release dosage form and to analyze their capability of detecting manufacturing differences, predicting in vivo performance, and evaluate method robustness.  ... Read More »

FDA: Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2): RFA-FD-003: Due: June 1, 2014

This FOA, issued by the Office of Medical Policy (OMP), Center for Drug Evaluation and Research, Food and Drug Administration, solicits grant applications from neutral, independent institutions and/or organizations that propose methods for convening a broad range of stakeholders, to include those with relevant expertise, and that would support conferences and meetings to explore and address medical policy issues during ... Read More »

NIH: Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2): RFA-AR-015

The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced ... Read More »

NIH: Atopic Dermatitis Research Network (ADRN) (U19): RFA-AI-14-033: Due: June 8, 2014

This Funding Opportunity Announcement (FOA) solicits applications from institutions to administer a multi-project, multi-institution program to conduct clinical research and provide the leadership and administrative responsibilities for the Atopic Dermatitis Research Network (ADRN). The ADRN conducts clinical research studies to better understand host defense mechanisms in the skin, by comparing responses to infections and vaccines, and underlying mechanisms, in healthy, ... Read More »

NIH: Modeling Immunity for Biodefense (U19): RFA-AI-028: Due: June 18, 2014

This Funding Opportunity Announcement (FOA) solicits applications from single institutions, or consortia of institutions, to participate in a network of research groups developing computational models of immunity to infectious diseases other than HIV/AIDS. Applications are sought to develop, refine and validate computational models of immune responses (1) during or following infection, and/or (2) before and after vaccination against an infectious ... Read More »

NIH: Leveraging a Recovery Act Resource to Accelerate Research on Neurodevelopment (R01): RFA-MH-15-400: Due: September 3, 2014

This Funding Opportunity Announcement (FOA) aims to stimulate the broader research community to utilize a resource funded through the American Recovery and Reinvestment Act of 2009 (Recovery Act) to generate and evaluate hypotheses about the complex interrelationships and multi-directional influences among genetics, brain maturation, neurocognitive function, and psychiatric symptoms during development. This FOA is a strategic effort to disseminate this ... Read More »

NIH: High Impact Neuroscience Research Resource Grants (R24), RFA-NS-14-006: Due: June 23, 2014

This funding opportunity announcement (FOA) supports high impact efforts to make resources available to neuroscience researchers.  Projects should engage in one or more of the following activities: propagation of cutting edge reagents or techniques, dissemination of resources to new user groups, or innovative approaches to increase the scale/efficiency of resource production and delivery.  Applications focused on technology or software development ... Read More »

NIH: Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21): PA-14-159: Due:

This Funding Opportunity Announcement (FOA) invites applications using the R21 award mechanism for translational research that moves evidence-based research findings toward the development of new interventions, programs, policies, practices, and tools that can be used by organizations in the community to help older adults remain healthy and independent, productively engaged, and living in their own homes and communities.  The goal ... Read More »